Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-blinded, Randomized, Parallel Design, Phase IIa Clinical Trial to Evaluate the Efficacy, Safety and PK of LCB01-0371 With Vancomycin Versus Vancomycin Monotherapy in Patients With MRSA Bacteremia
Conditions
Interventions
Delpazolid
Vancomycin
+1 more
Locations
6
South Korea
Chosun University Hospital
Gwangju, South Korea
Chonnam National University Hospital
Gwangju, South Korea
Seoul National University Bundang Hospital
Gyeonggi-do, South Korea
Korea University Ansan Hospital
Gyeonggi-do, South Korea
Severance Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Start Date
April 26, 2022
Primary Completion Date
February 21, 2024
Completion Date
March 18, 2024
Last Updated
May 6, 2025
Lead Sponsor
LigaChem Biosciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions